SECONDARY PHARMACOLOGICAL PREVENTION OF CARDIOVASCULAR DISEASES: OUR ABILITY IN CLINICAL PRACTICE
The most pressing issues of the secondary drug prevention of the most common cardiovascular diseases are focused. These are arterial hypertension, stable ischemic heart disease, chronicheart failure.
Saved in:
Main Authors: | E. V. Filippov, S. S. Yakushin |
---|---|
Format: | Article |
Language: | English |
Published: |
Столичная издательская компания
2015-12-01
|
Series: | Рациональная фармакотерапия в кардиологии |
Subjects: | |
Online Access: | https://www.rpcardio.online/jour/article/view/634 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
LISINOPRIL IMPLICATION IN THE CLINICAL PRACTICE
by: V. I. Podzolkov, et al.
Published: (2016-01-01) -
FEMALE SEX HORMONES AS MODULATORS OF GENDER DIFFERENCES IN RESPONSE TO PHARMACOTHERAPY OF CARDIOVASCULAR DISEASES
by: S. N. Tereshchenko, et al.
Published: (2015-12-01) -
ГИПЕРТРОФИЧЕСКАЯ КАРДИОМИОПАТИЯ И СОЧЕТАННАЯ КАРДИОЛОГИЧЕСКАЯ ПАТОЛОГИЯ : ОСОБЕННОСТИ ДИАГНОСТИКИ И ЛЕЧЕНИЯ
by: С. С. Якушин, et al.
Published: (2011-02-01) -
Candesartan cilexetil in cardiovascular prevention
by: A. Ya. Ivleva
Published: (2007-12-01) -
Chronic heart failure in out-patient practice: aetiology issues
by: S. M. Bogdanova, et al.
Published: (2008-08-01)